APA (7th ed.) Citation

National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Phase I Working Group. Meeting, National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Biochemical Modulators Advisory Group. Meeting, & National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. (1985). Minutes of the Phase I Working Group and the Biochemical Modulators Advisory Group, July 17-18, 1985. Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute.

Chicago Style (17th ed.) Citation

National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Phase I Working Group. Meeting, National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Biochemical Modulators Advisory Group. Meeting, and National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Minutes of the Phase I Working Group and the Biochemical Modulators Advisory Group, July 17-18, 1985. Bethesda, Md.: Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, 1985.

MLA (9th ed.) Citation

National Cancer Institute (U.S.). Cancer Therapy Evaluation Program. Investigational Drug Branch. Phase I Working Group. Meeting, et al. Minutes of the Phase I Working Group and the Biochemical Modulators Advisory Group, July 17-18, 1985. Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, 1985.